Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 |
| | 10-Q | 10-Q | 10-Q | 10-Q | 8-K | 10-Q | 10-Q | 10-K |
| Revenues |
| Clinical Solutions | | | | | | | 3,412.8 | 3,355.8 |
| Commercial Solutions | | | | | | | 1,048.3 | 1,060.0 |
| |
| EBITDA |
| Clinical Solutions | | | | | | | 554.1 | 543.4 |
| Commercial Solutions | | | | | | | 144.1 | 139.2 |
| |
| EBIT |
| Clinical Solutions | | | | | | | 554.1 | 543.4 |
| Commercial Solutions | | | | | | | 144.1 | 139.2 |
| |
| Mix |
| Clinical Solutions | | | | | | | 76.5% | 76.0% |
| Commercial Solutions | | | | | | | 23.5% | 24.0% |
| |
| Growth |
| Clinical Solutions | | | | | | | -3.3% | -2.7% |
| Commercial Solutions | | | | | | | -12.1% | -13.5% |
|